Purewater Capital LLC Purchases 5,224 Shares of iShares U.S. Pharmaceuticals ETF $IHE

Purewater Capital LLC acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 5,224 shares of the company’s stock, valued at approximately $525,000. iShares U.S. Pharmaceuticals ETF makes up 0.4% of Purewater Capital LLC’s investment portfolio, making the stock its 24th biggest holding.

A number of other hedge funds also recently added to or reduced their stakes in the company. MinichMacGregor Wealth Management LLC purchased a new stake in shares of iShares U.S. Pharmaceuticals ETF during the 3rd quarter valued at about $32,098,000. Cetera Investment Advisers raised its stake in iShares U.S. Pharmaceuticals ETF by 675.4% during the 1st quarter. Cetera Investment Advisers now owns 109,471 shares of the company’s stock valued at $9,489,000 after buying an additional 95,353 shares during the last quarter. Congress Asset Management Co. purchased a new stake in iShares U.S. Pharmaceuticals ETF during the 3rd quarter valued at $56,000. AdvisorNet Financial Inc purchased a new stake in iShares U.S. Pharmaceuticals ETF during the 3rd quarter valued at $5,224,000. Finally, Tidal Investments LLC purchased a new stake in iShares U.S. Pharmaceuticals ETF during the 2nd quarter valued at $3,716,000.

iShares U.S. Pharmaceuticals ETF Price Performance

IHE stock opened at $102.51 on Monday. The company has a market cap of $1.54 billion, a P/E ratio of 17.75 and a beta of 0.47. iShares U.S. Pharmaceuticals ETF has a 1 year low of $73.76 and a 1 year high of $108.66. The stock’s fifty day moving average price is $102.47 and its 200-day moving average price is $97.24.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.